Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron B Shmueli

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Acta Biomaterialia|August 3, 2019
Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularizationJayoung Kim, Raquel Lima E Silva, Ron B Shmueli, et al.
Science Translational Medicine|January 20, 2017
Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakageRaquel Lima E Silva, Yogita Kanan, Adam C Mirando, et al.
Molecular Systems Biology|March 7, 2022
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluriaDavid Lubkowicz, Nicholas G Horvath, Michael J James, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Acta Biomaterialia|August 3, 2019
Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularizationJayoung Kim, Raquel Lima E Silva, Ron B Shmueli, et al.
Science Translational Medicine|January 20, 2017
Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakageRaquel Lima E Silva, Yogita Kanan, Adam C Mirando, et al.
Molecular Systems Biology|March 7, 2022
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluriaDavid Lubkowicz, Nicholas G Horvath, Michael J James, et al.
Pageof 2